Effects of Diane-35 Combined with Metformin on Treatment of Polycystic Ovary Syndrome

YANG Zhi-ping; WU Xin

您当前的位置：

首页 >

文章列表页 >

Effects of Diane-35 Combined with Metformin on Treatment of Polycystic Ovary Syndrome

更新时间：2024-01-04

- Effects of Diane-35 Combined with Metformin on Treatment of Polycystic Ovary Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 17, Issue 11, Pages: 246-248(2011)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2011
- 稿件说明：
移动端阅览
YANG Zhi-ping, WU Xin. Effects of Diane-35 Combined with Metformin on Treatment of Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(11): 246-248.
DOI：

YANG Zhi-ping, WU Xin. Effects of Diane-35 Combined with Metformin on Treatment of Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(11): 246-248. DOI：

摘要

目的: 观察达英-35联合二甲双胍治疗多囊卵巢综合征(PCOS)的临床疗效。方法: 38例临床患者

口服达英-35和二甲双胍3个周期

观察治疗前后临床症状、性激素水平、瘦素(Lp)、胰岛素抵抗指数(HOMA-IR)、性激素结合球蛋白(SHBG)、体重指数(BMI)和卵巢形态学等指标

比较生殖内分泌指标及糖代谢指标的变化。结果: 用药后LH/FSH比值、雄激素水平、瘦素和胰岛素抵抗指数较治疗前均降低

性激素结合球蛋白较治疗前显著升高(P<0.01)。治疗后BMI下降(P<0.05)

卵巢体积较治疗前明显缩小(P<0.05)。结论: 达英-35联合二甲双胍可有效改善多囊卵巢综合征患者的胰岛素抵抗状态

降低血中雄激素水平并恢复生育功能

治疗多囊卵巢综合征安全有效。

Abstract

Objective: To investigate the clinical effects of Diane-35 with metformin on treating women with polycystic ovary syndrome(PCOS). Method: Thirty-eight patients took orally Diane-35 and metformin for 3 consecutive courses of treatment.Clinical symptoms

luteinizing hormone(LH)

follicle stimulating hormone(FSH)

Leptin

HOMA-IR

SHBG

BMI and the ovarian volume were kept under observation before and after taking Diane-35 and metformin.Reproductive hormones

serum glucose and insulin level were compared to that before therapy. Result: The content of LH/FSH

androgen

HOMA-IR were less than that before the treatmennt.The content of SHBG was more than that before taking medicine

and there were highly significant difference (P<0.01).The content of BMI was less than that before taking medicine

the size of ovaries was reduced and there were significant difference (P<0.05). Conclusion: Diane-35 and metformin are effective to reduce insulin resistance and androgen and to recover ovulation in women with PCOS.And the treatment was shown to be safe and effective.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Efficacy of Jianpi Bushen Recipe joint Metformin in Endocrine and Biochemical Festures of Obese PCOS Patients

Mechanism of Kidney-tonifying and Liver-regulating Cyclical Therapy and Formula in Improving Endometrial Receptivity during "Implantation Window" in Rats with Polycystic Ovary Syndrome via miR-140-5p/VEGF Pathway

Mechanism of Modified Guishenwan in Regulating AMPK/Akt/Nrf2 Pathway to Improve Glucose and Lipid Metabolism and Oxidative Stress in Polycystic Ovary Syndrome Rats

Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway

Signaling Pathways Related to Polycystic Ovary Syndrome and Regulation by Traditional Chinese Medicine： A Review

Related Author

ZHAI Jun

SUN Ying-pu

LIU Quan

HE Yiqing

ZHANG Ying

WANG Xi

YANG Shuo

TIAN Jiayu

Related Institution

Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases， Hunan University of Chinese Medicine

Hunan University of Chinese Medicine

The First Affiliated Hospital of Chongqing Medical University

The Third Affiliated Hospital of Henan University of Chinese Medicine

Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰